| Application no. and date | 19721103.0 (espacenet) (Federated) (European Patent Register), 20190328 | | Patent/reg. no. and date | DK/EP 3773595, 20230712 | | Publication date | 20210217 | | Priority no. and date | IT 201800004082, 20180329 | | EP pub. no. and date |
EP 3773595 20210217 | | Effective date | | | Applicant/owner | Berlin-Chemie AG, Glienicker Weg 125
12489 Berlin, DE | | Applicant ref. no. | V463274DK00 | | Inventor | MERLINO, Giuseppe, c/o Menarini Ricerche SPA Via Tito Speri 10
00071 Pomezia RM, IT,
BIGIONI, Mario, c/o Menarini Ricerche SPA Via Tito Speri 10
00071 Pomezia RM, IT,
BINASCHI, Monica, c/o Menarini Ricerche SPA Via Tito Speri 10
00071 Pomezia RM, IT,
PELLACANI, Andrea, Menarini Ricerche S.p.A. Via dei Sette Santi 1
50131 Firenze, IT | | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | | Opponent | | | IPC Class | A61K 31/5377 (2006.01) , A61K 39/395 (2006.01) , A61P 35/00 (2006.01) | | Title | Farmaceutiske anticancer-sammensætninger til kombineret terapi | | Int. application no. | IB2019052541 | | Int. publication no. | WO2019186451 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
